SAI MedPartners

SAI MedPartners is a private, revenue-generating consulting firm operating in the life sciences services sector. It provides integrated strategic insights across key functions like competitive intelligence, market research, and commercial planning to help pharma, biotech, and medtech companies navigate complex market landscapes. With a global footprint spanning the US, EU, and Asia, and leadership composed of industry veterans, the company has established itself as a trusted partner, claiming strategic support for 31% of New Molecular Entities launched since 2021. Its business model is built on delivering senior-level, customized advisory services rather than developing its own therapeutic or device products.

Integrated consulting methodology combining competitive intelligence, market research, forecasting, and benchmarking with therapeutic area expertise and AI-enhanced analytics. Key tools include the Deployment Analyzer for commercial benchmarking.

SAI competes in a fragmented market against large diversified consultancies (e.g., IQVIA, McKinsey, BCG), specialized life sciences boutiques, and the internal strategy teams of its clients. Its differentiation is based on an integrated service model, deep therapeutic area expertise, and a claim of senior-level engagement on high-stakes product launches.